Immunogenicity of meningococcal ACYW135 polysaccharide vaccine in Saudi children 5 to 9 years of age

被引：13
|
作者：
Khalil, M
Al-Mazrou, Y
Balmer, P [1 ]
Bramwell, J
Andrews, N
Borrow, R
机构：
[1] Manchester Royal Infirm, HPA North West Lab, Meningococcal Reference Unit, Manchester M13 9WZ, Lancs, England
[2] King Fahad Specialist Hosp, Med Educ & Res Ctr, Qasim, Saudi Arabia
[3] Minist Hlth, Dept Prevent Med, Riyadh, Saudi Arabia
[4] HPA Ctr Infect, Stat Unit, London NW9 5EQ, England
来源：
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY | 2005年 / 12卷 / 10期
关键词：
D O I：
10.1128/CDLI.12.10.1251-1253.2005
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Meningococcal tetravalent polysaccharide vaccines were observed to be immunogenic in Saudi children 5 to 9 years of age, with > 90% having serum bactericidal antibody titers of >= 8 for serogroups A, Y, and W135; for serogroup C, 77% were putatively protected after vaccination.
引用
收藏
页码：1251 / 1253
页数：3
相关论文
共 50 条
  • [31] Safety and immunogenicity of meningococcal (Groups A and C) polysaccharide vaccine in children 2 to 6 y of age in China: a randomized, active-controlled, non-inferiority study
    Zhu, Feng-Cai
    Hu, Yue-Mei
    Li, Ya-Nan
    Shu, Jean-Denis
    Oster, Philipp
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2021, 17 (03) : 919 - 926
  • [32] Immunogenicity of quadrivalent human papillomavirus vaccine among Alaska Native children aged 9-14 years at 5 years after vaccination
    Davis, Bionca M.
    Blake, Ian
    Panicker, Gitika
    Meites, Elissa
    Thompson, Gail
    Geis, Jesse
    Bruden, Dana
    Fischer, Marc
    Singleton, Rosalyn
    Unger, Elizabeth R.
    Markowitz, Lauri E.
    Bruce, Michael G.
    VACCINE, 2024, 42 (14) : 3277 - 3281
  • [33] The immunogenicity and safety of an investigational meningococcal serogroups A, C, W-135, Y tetanus toxoid conjugate vaccine (ACWY-TT) compared with a licensed meningococcal tetravalent polysaccharide vaccine A randomized, controlled non-inferiority study
    Dbaibo, Ghassan
    Macalalad, Noel
    Aplasca-De Los Reyes, Mari Rose
    Dimaano, Efren
    Bianco, Veronique
    Baine, Yaela
    Miller, Jacqueline
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2012, 8 (07) : 873 - 880
  • [34] Reactogenicity and immunogenicity of a single dose of typhoid Vi polysaccharide vaccine in children aged between 4 and 14 years
    Pelser, HH
    BIODRUGS, 2001, 15 (Suppl 1) : 13 - 19
  • [35] Reactogenicity and Immunogenicity of a Single Dose of Typhoid Vi Polysaccharide Vaccine in Children Aged between 4 and 14 Years
    Helena H. Pelser
    BioDrugs, 2001, 15 : 13 - 19
  • [36] Reactogenicity and immunogenicity of a Lyme disease vaccine in children 2-5 years old
    Beran, J
    De Clercq, N
    Dieussaert, I
    Van Hoecke, C
    CLINICAL INFECTIOUS DISEASES, 2000, 31 (06) : 1504 - 1507
  • [37] Immunogenicity of Fractional Doses of Tetravalent A/C/Y/W135 Meningococcal Polysaccharide Vaccine: Results from a Randomized Non-Inferiority Controlled Trial in Uganda
    Guerin, Philippe J.
    Naess, Lisbeth M.
    Fogg, Carole
    Rosenqvist, Einar
    Pinoges, Loretxu
    Bajunirwe, Francis
    Nabasumba, Carolyn
    Borrow, Ray
    Froholm, Leif O.
    Ghabri, Salah
    Batwala, Vincent
    Twesigye, Rogers
    Aaberge, Ingeborg S.
    Rottingen, John-Arne
    Piola, Patrice
    Caugant, Dominique A.
    PLOS NEGLECTED TROPICAL DISEASES, 2008, 2 (12):
  • [38] SAFETY, REACTOGENICITY AND IMMUNOLOGICAL POTENCY OF GROUP-A MENINGOCOCCAL POLYSACCHARIDE VACCINE FOR CHILDREN AGED 1-4 YEARS
    CHERNYSHOVA, TF
    MISHINA, AI
    PAVLOVA, LI
    POKROVSKAYA, NY
    SOKOLOVA, TV
    SKIRDA, TA
    CHERNYSHOVA, MS
    SAVCHENKO, LG
    RYUSS, LI
    KUVAKINA, VI
    GOFMAN, IL
    ZHURNAL MIKROBIOLOGII EPIDEMIOLOGII I IMMUNOBIOLOGII, 1987, (05): : 54 - 58
  • [39] Safety, immunogenicity, and immune memory of a novel meningococcal (groups A, C, Y, and W-135) polysaccharide diphtheria toxoid conjugate vaccine (MCV-4) in healthy adolescents
    Keyserling, H
    Papa, T
    Koranyi, K
    Ryall, R
    Bassily, E
    Bybel, MJ
    Sullivan, K
    Gilmet, G
    Reinhardt, A
    ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE, 2005, 159 (10): : 907 - 913
  • [40] Safety and Immunogenicity of an Inactivated Quadrivalent Influenza Vaccine in Children 6 Months through 8 Years of Age
    Greenberg, David P.
    Robertson, Corwin A.
    Landolfi, Victoria A.
    Bhaumik, Amitabha
    Senders, Shelly D.
    Decker, Michael D.
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2014, 33 (06) : 630 - 636
12345